Arvinas Inc

Arvinas CFO’s tax‑driven sale of 11,139 shares amid a high‑profile licensing deal shows insiders stay bullish, not a confidence drop – read the full insider‑trade analysis.

Arvinas insider activity shows routine RSU tax sales by Chief Medical Officer Noah Berkowitz, while top execs boost confidence with bulk buying amid promising Parkinson’s trial data.

Arvinas insider sales are routine, not a red‑flag. Loomis’s tax‑sale shows standard RSU settlement; the company’s biotech pipeline remains a key focus.